Genetic Engineering & Biotechnology News recently published a feature story entitled ‘Immune Cell Therapy May Become More Naturalistic'.
Topic: Media Coverage
-
January 10, 2024
Naturally Occurring Immune Cells may push through where CAR T cells fall short, reports Genetic Engineering and Biotechnology News
Read More -
October 24, 2023
SUPLEXA in the news
Dr. Borriello on ‘first in human’ podcast by Vial
Frank Borriello, the mind behind SUPLEXA cell therapy, and the CEO and founder of Alloplex Biotherapeutics recently appeared as a guest on the ‘First In Human’ podcast by Vial.
Read More -
August 20, 2021
Alloplex in the News ‘Daewoong and HanAll invest in Alloplex’
This week, BioSpectrum Asia reported the news of Daewoong Pharmaceutical Co., Ltd. and HanAll BioPharma Co., Ltd.’s investment in Alloplex Biotherapeutics, Inc. this week. Here is a copy of that coverage.
Read More